IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia

International Journal of Gynecological Cancer

Volumn 10, Issue 4, 2000, Pages 296-304

  Tjiong, M Y ^a   Ter Schegget, J ^a   Tjiong A Hung, S P ^a   Out, T A ^a,b   Van Der Vange, N ^c   Burger, M P M ^a   Struyk, L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Antibodies; Cervical cancer; CIN; HPV 16 E7; Local immunity

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; ONCOPROTEIN; ONCOPROTEIN 16; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PLASMA CELL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; VIRUS ONCOGENE; WART VIRUS;

EID: 0033823151     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.010004296.x     Document Type: Article

References (45)

1. Papillomavirus infections - A major cause of human cancers
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) study group
3. Aetiology, pathogenesis, and pathology of cervical neoplasia
4. Human papillomavirus infection is transient in young women: A population-based cohort study
5. Transience of cervical hpv infection in sexually active, young women with normal cervicovaginal cytology
6. Human papillomavirus infection in women infected with the human immunodeficiency virus
7. Mucosal immunity in the female genital tract
8. Mucosal immunity in the female and male reproductive tracts
9. Normal uterine cervix: Characterization of isolated lymphocyte phenotypes and immunoglobulin secretion
10. Systemic and secretory humoral immunity in the normal human vaginal tract
11. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia
12. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients
13. Seric and local antibodies against a synthetic peptide of HPV16
14. Human papillomavirus DNA and anti-HPV secretory IgA antibodies in cytologically normal cervical specimens
15. Immune responses against human papillomavirus (HPV) type 15 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
16. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients
17. Comparison of peptide enzyme-linked immunosorbant assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins
18. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions
19. Telomerase activity as a biomarker for (pre) neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear
20. Human papillomavirus type 16 DNA sequence
21. Identification of a unique group of human papillomavirus type 16 sequence variants among clinical isolates from Barbados
22. Detection of cutaneous and genital hpv types in clinical samples by PCR using consensus primers
23. Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions
24. Immunoglobulin production in human mixed lymphocyte cultures: Implications for co-cultures of cells from patients and healthy donors
25. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
26. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: Prognostic value of anti-E6 and/or anti-E7 antibodies
27. A rapid immunofluorescent procedure for the detection of specific IgG and IgM antibody in sera using Staphylococcus aureus and latex-IgG absorbents
28. Immunologic responses to human papillomavirus infection
29. Serological immune response to HPV
30. Antibodies to HPV-16 E6 and E7 proteins as markers for hpv-16- associated invasive cervical cancer
31. Serologic response in human papillomavirus-associated invasive cervical cancer
32. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children
33. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins
34. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer
35. HPV-16-related proteins as the serologic markers in cervical neoplasia
36. Molecular biology of cervical cancer and its precursors
37. HLA antigens and cervical carcinoma
38. HLA antigens and cervical carcinoma
39. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: Local anamnestic responses after genital HSV-2 infection
40. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections
41. Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine
42. Cervicovaginal over-production of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection
43. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: Implications for the immunologic response to HIV in the female genital tract